Protocol
Abstract
Background: Diabetic retinopathy (DR), a leading cause of preventable blindness among working-age adults, leads to worse health outcomes among Black, Latine, and individuals with lower income in comparison to other ethnic, racial, and socioeconomic groups in the United States.
Objective: We aim to engage community members directly to identify barriers and facilitators of DR screening and co-design a digital health tool that is accessible, user-friendly, and community-responsive.
Methods: We conducted focus groups with individuals from the Greater New Haven, Connecticut area, aged 18 years or older, and diagnosed with diabetes to (1) conduct a comprehensive disease-management needs assessment and (2) inform the development of a community-responsive digital health tool to optimize DR education and to increase access to DR screening in high-risk populations. We transcribed the focus group interviews, used rapid qualitative analysis to generate themes, and completed affinity mapping to identify content and features for a digital health tool for preventing blindness from DR.
Results: We recruited and interviewed 19 individuals (13/19, 68% female; 9/19, 47% Black; 5/19, 26% Hispanic; 2/19, 11% Native American or Alaska Native) for 4 focus groups. Over 94% (18/19) had access to smart devices other than a computer. Participants self-reported mean hemoglobin A1c of 6.77 (SD 1.93). Approximately 58% (11/19) of the participants completed some college. Frequently occurring themes (>30) obtained from coding contextual interviews were desired app attributes such as options for customization, covering topics such as, the mental impact of living with diabetes, informal support (eg, peer support), diabetes education, barriers to controlling blood sugar and maintenance of health, dietary guidance, and notifications. We created high-fidelity wireframes incorporating key features. Next, we will iteratively design a prototype with community feedback.
Conclusions: We anticipate that this study will characterize the experiences of people living with diabetes. Using a community-led approach,we will continue to analyze the data that will generate insights regarding the key features, content, and benefits that are most important for the creation of a digital health tool for DR prevention.
International Registered Report Identifier (IRRID): DERR1-10.2196/65894
doi:10.2196/65894
Keywords
Introduction
Diabetic retinopathy (DR), a leading cause of preventable blindness among working-age adults, represents a significant public health challenge, particularly among racial and ethnic minoritized communities in the United States [,]. Despite advances in therapeutic interventions, disparities in screening and treatment outcomes persist, disproportionately affecting non-Hispanic Black, Latine, American Indian, Alaska Native, and lower-resourced communities [-]. These groups are less likely to be screened for DR and are more likely to present at advanced stages of the disease. They also face significant barriers to follow-up care, which ultimately leads to a higher prevalence and severity of the condition [-].
The underutilization of DR screening services in these high-risk populations highlights a critical gap in our current health care delivery models, which fail to account for the nuanced needs of diverse communities. Moreover, existing health technologies, including mobile health tools, often do not reach or effectively serve marginalized groups, further exacerbating health disparities [-]. This inequity stems from a variety of complex factors, including socioeconomic conditions, structural racism, historical underrepresentation in health research, and lack of culturally tailored health interventions [-].
Addressing these challenges requires innovative approaches that embrace technological solutions while prioritizing community engagement and responsiveness to underserved populations’ specific needs and preferences []. Utilizing feedback from intended users and understanding their technology usage and behaviors can mitigate the risk of perpetuating further inequalities [-]. Thus, the primary objective of this study is to develop and evaluate a novel digital health tool designed to enhance DR screening rates and health education through a community-driven design. By integrating community insights into every stage of the development process, this project aims to bridge the gap between evidence-based screening practices and the actual utilization of these services among those most at risk.
Findings from the 2005 to 2008 National Health and Nutrition Examination Survey showed that 10.6% of their US cohort aged ≥40 years, representing an estimated 9.8 million individuals nationally, were unaware that they had DR []. Through a community-led research approach, this project will engage community members directly to identify the barriers and facilitators of DR screening and co-design a digital tool that is accessible, user-friendly, and culturally relevant. The anticipated outcome is a scalable digital health solution that not only increases DR screening rates but also serves as a model for addressing health care disparities in other domains.
Methods
Study Design, Study Setting, and Participants
This protocol has 2 specific aims: (1) to complete a comprehensive needs assessment and (2) to develop a community-responsive digital health tool to increase access to DR screening in high-risk populations and optimize DR education. There will be 4 phases that encompass the 2 aims of the protocol: needs assessment, design, development, and evaluation ( and ). This protocol has been initiated, and we have completed our first aim. We are currently working on our second aim. We recruited individuals with diabetes mellitus from the Greater New Haven, Connecticut area. Results from a study by Guest et al [] revealed that more than 80% of all themes are discoverable within 2-3 focus groups, and 90% of themes could be discovered within 3-6 focus groups. To ensure rich discussion and engagement, we planned to conduct 4 focus groups with 5-8 participants each session, as smaller groups facilitate deeper participant interaction while still allowing for diverse perspectives.


This research was conducted with the Sight-Saving Engagement and Evaluation in New Haven (SEEN) Lab at the Yale School of Medicine and the Consumer Health Informatics Lab (CHIL) at Yale School of Public Health. The SEEN Lab combines quantitative and qualitative research methods to address health disparities in DR by designing sustainable community-engaged solutions toward equity. CHIL engages in cutting-edge research, focusing on inclusive design and usability testing of consumer health products for diverse populations.
We developed this study in collaboration with the community-engaged research steering committee, a longstanding academic-community partnership. Members of this group provided insight into community-level needs and individual capacities. We convened an advisory board that includes local stakeholders, health care providers, and community leaders to provide insights into the community needs and to guide the research process, ensuring the tool’s development is grounded in real-world contexts. At every phase of this study, we will convene to disseminate findings to the board and to receive guidance on our design and methods in order to continuously address specific community needs and contexts. Each advisory board member will receive a US $50 gift card per advisory board meeting attended.
Aim 1: Completing a Community Needs Assessment
The first aim of the protocol focuses on conducting a community needs assessment.
Phase 1: Needs Assessment
Research Design and Data
For our digital health tool, we used 4 theoretical frameworks to help formulate a community needs assessment. The Equity-focused Dissemination and Implementation framework, which provides a foundation for the operationalization of widespread health equity research implementation, served as the overarching guidance for our study’s development []. The Consolidated Framework for Implementation Research informed our study’s methodological structure to convene an advisory board, conduct focus groups, and subsequently analyze the focus group transcripts, as this framework gives guidance on organizing implementation [,]. The Four Is of Health Equity provide strategies on how to reduce health disparities and promote health equity []. We used this framework to steer our study’s objective to focus on identifying health disparities and implementing evidence-based interventions to reduce disparities. The COREQ (Consolidated Criteria for Reporting Qualitative Research) checklist provided a guided reflection of the study upon submission of the manuscript. Lastly, the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework informed the metrics the research team will use to evaluate the design process of the digital health tool [].
Recruitment and Interviewing of Individuals Living With Diabetes
Research team members from the SEEN Lab (JF, TC, AF) and CHIL (BA, MK) recruited participants from the Yale Eye Center, primary care offices, and community settings such as restaurants and libraries. We engaged directly with the community through connections and community networks across Greater New Haven community clinics, faith-based organizations, and the Yale New Haven Hospital network []. To be eligible for the focus group, participants needed to be at least 18 years old, have a diagnosis of type 1 or type 2 diabetes mellitus, speak English fluently, and be able to attend the interview in person. Although the ability to speak English fluently restricted the inclusivity of our cohort, it was necessary to make this restriction to efficiently design the first prototype of the tool. Future iterations of the tool will account for non-English speakers. Each participant received a US $50 gift card for their participation.
Data Collection
The research team (AF, JF, TC, BA, KHN, TM, MS, QY) developed an interview guide in collaboration with the advisory board (). The interview guide includes questions about the participants’ experiences with diabetes, their eye health awareness, their technology usage, and their preferences for features in a digital tool to learn about eye health and screening. We collected data from October to November 2023. Semistructured focus group interviews were conducted to gathered qualitative data on participant experiences with diabetes management, awareness of DR, and perceptions of existing health technologies. One member from the research team (AF) served as the moderator, and the remainder served as notetakers (BA, MK, JF, TC, KHN, VHK). The focus groups were audio-recorded, professionally transcribed, and analyzed [,]. Participants provided informed consent prior to the interview, and identifying information was removed from the transcript to preserve confidentiality.
Data Analysis
The analytic team comprised of members from the SEEN Lab and CHIL (TC, JF, BA, AF, MK, AG, SSA, AL, KHN, TM). Following each focus group interview, the research team conducted the rapid qualitative analysis method to efficiently process data and facilitate interpretation sessions [,]. This method allowed the team to systematically collect and analyze participants’ thoughts and experiences within a shorter timeframe []. Before the first focus group session, the analytical team developed a structured template () to organize key insights, including the research team members’ initial impressions, detailed accounts of participants’ experiences with diabetes care and the use of technology in health care and eye care, and the team member’s’ summative thoughts on each interview. The research team made minor adjustments to the template as needed to gather more information about eye care experiences. Next, the research team engaged in a series of interpretation sessions with affinity mapping, which is a collaborative process to thematically analyze qualitative data []. To keep the information organized, the information was compiled using Miro []—an online visual collaboration tool that uses digital sticky notes to help teams organize and synthesize their thoughts. These sessions were moderated by a facilitator (TM). The objective of these sessions was to analyze all the data, which included the original transcripts, summary documents from the rapid review, and notes from each focus group, to systematically code the interviews, categorize responses into emerging themes, and prioritize features. Over multiple sessions, these sticky notes were reorganized to create thematic categories, which will be used to create draft models for the design of the digital health tool [].
Aim 2: Development of a Community-Based Digital Health Tool
The second aim consists of 3 phases: design, development, and evaluation of the digital health tool for DR prevention.
Phase 1: Design
The design phase leverages insights from the focus groups in the needs assessment phase to cocreate the digital health tool with community members. Using the list of app features and content generated from focus group analysis, the research team created detailed user journey maps to visualize different user experiences as the participants, advisory board members, and other stakeholders interact with the tool—identifying pain points and opportunities to enhance user engagement. First, the research team will collaborate with the advisory board to develop culturally tailored health education content for the tool, including engaging and informative materials on DR, its risk factors, and the importance of regular screening. Then, the research team will develop low-fidelity wireframes and interactive prototypes. These prototypes will be tested and refined through usability testing sessions with community members to ensure that the tool is intuitive and user-friendly.
Phase 2: Development and Usability Testing
The next phase consists of building the digital health tool, which will involve translating design prototypes into a functional digital health tool. The research team will collaborate with designers and app developers to build the tool, ensuring it is accessible on various devices and integrates seamlessly with existing health care systems. Lastly, the research team will conduct a usability testing phase with a select group of intended users from the target population. The RE-AIM framework will guide the research team in choosing participants who are representative of the target population and the internal discussion among the research team regarding the tool, especially whether the tool has effectively improved health care management through keeping appointments, encouraging discussion about diabetes, and empowering users to make more informed choices in diet and exercise. The adoption criterion of RE-AIM will also encourage reflection on whether the tool is serving its target population directly. The team will summarize usability walk-through sessions qualitatively. Tobii eye-tracking software will be used to produce heat maps that identify the focus of the participants’ attention on screens to inform user interface design. We will administer the Questionnaire for User Interface Satisfaction and analyze and summarize the open-ended portion. Areas that require optimization will be discussed with the design team, and well-designed areas will be highlighted. Efficiency will be measured by the time required to complete a series of tasks within the app prototype and the number of taps needed to complete each task. We will obtain information on user satisfaction with the app from the metrics calculated from the Questionnaire for User Interface Satisfaction. Statistical analysis will be conducted using SPSS (version 26; IBM Corp). The results of usability testing will inform the app design and help refine the features of the tool through iterative design. Next, we will evaluate the impact of the tool.
Phase 3: Evaluation
The final phase, evaluation, will focus on assessing the tool’s impact and effectiveness in increasing DR screening rates. We will implement a pilot study to evaluate the tool in a real-world setting by using the RE-AIM framework to assess its reach, effectiveness, adoption, implementation, and maintenance. Feedback from our intended users will be gathered during the pilot. The feedback will be used to identify and resolve problems, improve usability, and refine tool features before the full launch. We will collect quantitative and qualitative data from users—tracking screening rates, user engagement metrics, and participant feedback.
Lastly, we will conduct iterative usability testing sessions with a diverse group of end users to continuously improve the tool’s interface and functionality. The participants will be adults recruited from local community organizations such as the Dixwell Congregational Church, a historically Black church, with a congregation that spans the ages from children to older adults (65 years and older). Insights from these sessions will inform ongoing adjustments to enhance user experience and ensure the tool meets the community’s needs.
Ethical Considerations
This study received approval from the Yale School of Medicine Institutional Review Board (IRB # 2000034710). All research procedures were followed in accordance with the Yale School of Medicine institutional review board and the World Medical Association’s Declaration of Helsinki. All participants provided informed consent and were given the opportunity to opt out at any time during the study. All data pertaining to the results of focus groups and related subsequent analyses were deidentified to maintain privacy and confidentiality, and participant-protected health information was stored on an encrypted Yale University information technology department–managed SharePoint server with access restricted to authorized research team members. No images in this manuscript contain participant-identifiable information. Participants received a US $50 gift card for their participation, and advisory board members also received a US $50 gift card for their participation.
Results
As of December 2023, we completed 4 focus groups with 19 participants. Data from the interviews were used by the research team to conduct descriptive rapid analysis of each focus group session transcript and categorize common themes: the need for enhanced diabetes knowledge, diet-related guidance, informal support through peer connections, integration with electronic health records, and mental health support needed for individuals living with diabetes. The research team then conducted interpretation sessions from February 2024 to April 2024 to efficiently process data, identify pain points, and share findings with the broader study team to start the design process. The team identified features that address the themes of needs expressed by the participants interviewed. The features included a social media component that allows “following” and “liking” posts to create a supportive community, a curated library of recipes for nutritional guidance for people with diabetes, customizable home screens and health metrics like body mass index calculations, integration of functions and data within the MyChart app, appointment reminders, and a curated library of sources of information that served both as a reference for the user and as the training data for a large language model to answer the user’s questions reliably. As of April 2025, the design sprint has been completed, with low and high-fidelity wireframes incorporating the planned features. The next step is to plan for the app’s development and implementation.
Discussion
Overview
In the United States, approximately 9.6 million individuals are diagnosed with DR []. Unfortunately, many living with DR face barriers to screening and treatment [,,]. DR is a leading cause of blindness, which is preventable and often treatable when patients are empowered to receive timely screening and treatment [,,]. Advancements in technology, such as personal digital health libraries, have helped increase patient engagement and provide the general population with instant access to medical records, including diagnoses and treatment options. Yet, communities of color, Latine, and individuals with lower income are diagnosed and treated less often, experience worse outcomes, and generally engage less with DR care [-].
Anticipated Findings
We anticipate that the patient community with DR needs a culturally responsive digital health tool that prioritizes the communities it serves. Valuable insights from the first phase of the study will enable our development of a tool that aligns with the vision held by the communities it serves. Our community-based approach not only lifts the voices of participants from communities, which often go unheard in health care research, but will also empower them through an educational component, including connecting the participants to resources to help them manage DR.
The culturally responsive digital health tool will include 3 components: a risk calculator, educational features, and self-scheduling software. The risk calculator will help assist providers, especially eye care providers, in clinical decision-making to identify if patients are at a high risk of certain ophthalmic diseases []. The educational features will include a large library of curated sources and information, which will also serve to train an artificial intelligence chatbot that will be able to answer queries for users. The self-scheduling software tool will be able to assist with health care navigation by providing appointment reminders and suggestions on which medical practitioners are most recommended by patients.
We will co-design the tool with community partners and continue by using coded interview and user experience data as a guide to iteratively design and evaluate the efficacy of our digital health tool as it is developed. We expect the digital health tool to be well received by and engaging for the Black, Latine, and lower-income communities. We will adhere to the RE-AIM framework to guide the dissemination of our tool, starting with local communities.
Study Limitations
This study will provide valuable information to help create a digital health tool, however several anticipated limitations can and have appeared in this study. In using focus groups as a methodological approach, there are some limitations that can arise. Some challenges that can arise include recruitment of participants, group dynamics, group composition, sample size, dynamics, and logistic barriers. When designing focus group sessions, a moderate sample size and number of sessions allow for a diverse range of participant experiences and perspectives, ensuring meaningful insights []. Although literature suggests a minimum of 4 focus groups for qualitative research, sometimes there is potential for a limited sample size due to various circumstances such as accessibility due to timing, transportation, and availability [,]. Despite the research team’s best efforts, participant availability and logistical barriers impacted attendance. Some focus groups had higher attendance than others. The research team recognized this possibility and scheduled multiple sessions in advance, providing convenient weekday and evening sessions, and were flexible to increasing the number of focus group sessions, if needed, to ensure data saturation []. Although we could not provide virtual participation, that may be a possibility for future focus group sessions that may allow more accessibility for participants. We also acknowledge that during the recruitment period, we were only able to enroll participants fluent in English. As a result, some individuals were excluded, as proficiency in English was necessary for participation. Future studies could address this limitation by incorporating focus groups with non-English speakers (eg, Spanish only) participants to ensure their perspectives are represented, particularly as they are part of the racial and ethnic minoritized populations.
One inherent limitation of focus group research is selection bias, as participants may not fully represent the broader population. Instead, they tend to provide a snapshot of perspectives from those who chose to participate []. The research team aimed to recruit participants with relevant experiences to provide meaningful insights []. We carefully considered group composition in terms of number, gender, and age distribution [,]. Our focus was to provide a diverse range of perspectives within each focus group. Although we aimed to recruit a diverse sample, we recognize that certain demographic groups may have been underrepresented.
Given the study’s setting within a smaller urban community, there was a possibility that participants knew or were familiar with one another. During the focus group sessions, we emphasized confidentiality at the beginning of each session and ensured that facilitators guided discussions in a way that maintained privacy and encouraged broad, nonidentifying contributions.
Another potential limitation we anticipated was participants’ cultural mistrust, which could influence participants’ willingness to share personal experiences []. To foster a comfortable and trusting environment, we ensured that the moderators, facilitators, and/or notetakers were members of the same cultural or community group as the participants. This approach aimed to build rapport and encourage open discussion while minimizing reluctance to disclose information.
Despite these limitations, we believe our approach allowed us to gather meaningful insights that contribute to our study objectives.
Conclusion
Despite the existence of effective treatments for DR, historically marginalized populations experience poorer health outcomes, including irreversible vision loss. Personal health information technologies have focused on developing patient portals that facilitate communication between patients and providers and enable control of information by the patients themselves. However, their one-size-fits-all approach leaves behind communities of color, Latine, and lower-income communities. Our community-based approach empowers the creation of a culturally responsive digital health tool that will engage more of the patient population with DR.
Acknowledgments
The authors would like to acknowledge the participants for taking the time to graciously share their personal experiences. We would like to thank the members of the community-engaged research steering committee, Reverend Dr Frederick J Streets, and the advisory board members (Dr Annette Streets, Mr Richard Furlow, Tyisha Walker-Myers, Reverend Andre Gilford). We would also like to thank the director and staff from the Dixwell Community House Q house for providing the space to conduct the focus groups and for helping us find local vendors and caterers to provide dinner during the sessions, which supported local businesses and reinforced our commitment to keeping the study’s impact within the community. We would like to thank the Yale Eye Center for supporting participant recruitment. The authors would like to give special thanks to the Consumer Health Informatics Lab at Yale University for their support in conducting this study. This study received support and funding from the National Center for Advancing Translational Science/National Institutes of Health/US Department of Health and Human Services.
Conflicts of Interest
TM is an associate editor of the Journal of Medical Internet Research. KHN is funded by the National Institutes of Health (1 K23 EY030530-01), an unrestricted grant from the Research to Prevent Blindness, Inc, and a grant from the Yale Center for Clinical Investigations supported the work in this manuscript.
Focus group topic guide.
DOCX File , 15 KBDiabetic retinopathy digital health tool focus group interview summary template.
DOCX File , 18 KBCOREQ checklist.
DOCX File , 33 KBReferences
- Morello CM. Etiology and natural history of diabetic retinopathy: an overview. Am J Health Syst Pharm. Sep 01, 2007;64(17 Suppl 12):S3-S7. [CrossRef] [Medline]
- Spanakis EK, Golden SH. Race/ethnic difference in diabetes and diabetic complications. Curr Diab Rep. Dec 2013;13(6):814-823. [FREE Full text] [CrossRef] [Medline]
- Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. Ophthalmology. May 1991;98(5):766-785. [FREE Full text] [CrossRef]
- Barsegian A, Kotlyar B, Lee J, Salifu M, McFarlane S. Diabetic retinopathy: focus on minority populations. Int J Clin Endocrinol Metab. 2017;3(1):034-045. [FREE Full text] [CrossRef] [Medline]
- Ravindranath R, Bernstein IA, Fernandez KS, Ludwig CA, Wang SY. Social determinants of health and perceived barriers to care in diabetic retinopathy screening. JAMA Ophthalmol. Dec 01, 2023;141(12):1161-1171. [CrossRef] [Medline]
- Lu Y, Serpas L, Genter P, Mehranbod C, Campa D, Ipp E. Disparities in diabetic retinopathy screening rates within minority populations: differences in reported screening rates among African American and Hispanic patients. Diabetes Care. Mar 2016;39(3):e31-e32. [CrossRef] [Medline]
- Shi Q, Zhao Y, Fonseca V, Krousel-Wood M, Shi L. Racial disparity of eye examinations among the US working-age population with diabetes: 2002-2009. Diabetes Care. 2014;37(5):1321-1328. [FREE Full text] [CrossRef] [Medline]
- Canedo JR, Miller ST, Schlundt D, Fadden MK, Sanderson M. Racial/ethnic disparities in diabetes quality of care: the role of healthcare access and socioeconomic status. J Racial Ethn Health Disparities. Feb 2018;5(1):7-14. [FREE Full text] [CrossRef] [Medline]
- Callier S, Fullerton SM. Diversity and inclusion in unregulated mHealth research: addressing the risks. J Law Med Ethics. Mar 2020;48(1_suppl):115-121. [FREE Full text] [CrossRef] [Medline]
- Wherry K, Zhu C, Vigersky RA. Inequity in adoption of advanced diabetes technologies among Medicare fee-for-service beneficiaries. J Clin Endocrinol Metab. Apr 19, 2022;107(5):e2177-e2185. [CrossRef] [Medline]
- Yao R, Zhang W, Evans R, Cao G, Rui T, Shen L. Inequities in health care services caused by the adoption of digital health technologies: scoping review. J Med Internet Res. Mar 21, 2022;24(3):e34144. [FREE Full text] [CrossRef] [Medline]
- Eruchalu CN, Pichardo MS, Bharadwaj M, Rodriguez CB, Rodriguez JA, Bergmark RW, et al. The expanding digital divide: digital health access inequities during the COVID-19 pandemic in New York city. J Urban Health. Apr 2021;98(2):183-186. [FREE Full text] [CrossRef] [Medline]
- Chesser A, Burke A, Reyes J, Rohrberg T. Navigating the digital divide: a systematic review of eHealth literacy in underserved populations in the United States. Inform Health Soc Care. 2016;41(1):1-19. [CrossRef] [Medline]
- Hoppe C, Kerr D. Minority underrepresentation in cardiovascular outcome trials for type 2 diabetes. Lancet Diabetes Endocrinol. Jan 2017;5(1):13. [CrossRef] [Medline]
- Campos-Castillo C, Mayberry L. Chapter 21 - Disparities in digital health in underserved populations. In: Diabetes Digital Health and Telehealth. Cambridge, MA. Academic Press; 2022:269-280.
- Baxter SL. Representation matters-diversity in retina clinical trials. JAMA Ophthalmol. Nov 01, 2022;140(11):1103-1104. [CrossRef] [Medline]
- Cuevas AG, O'Brien K, Saha S. African American experiences in healthcare: "I always feel like I'm getting skipped over". Health Psychol. Sep 2016;35(9):987-995. [CrossRef] [Medline]
- Wu Y, Li Y, Baskys A, Chok J, Hoffman J, Roosan D. Health disparity in digital health technology design. Health Technol. Jan 10, 2024;14(2):239-249. [CrossRef]
- McCall T, Ali MO, Yu F, Fontelo P, Khairat S. Development of a mobile app to support self-management of anxiety and depression in African American women: usability study. JMIR Form Res. Aug 17, 2021;5(8):e24393. [FREE Full text] [CrossRef] [Medline]
- McCall T, Threats M, Pillai M, Lakdawala A, Bolton CS. Recommendations for design of a mobile application to support management of anxiety and depression among Black American women. Front Digit Health. 2022;4:1028408. [FREE Full text] [CrossRef] [Medline]
- Foumakoye M, Britton MC, Ansari E, Saunders M, McCall T, Wang EA, et al. Personal health libraries for people returning from incarceration: protocol for a qualitative study. JMIR Res Protoc. May 03, 2023;12:e44748. [FREE Full text] [CrossRef] [Medline]
- Nwanyanwu KM, Nunez-Smith M, Gardner TW, Desai MM. Awareness of diabetic retinopathy: insight from the National Health and Nutrition Examination Survey. Am J Prev Med. Dec 2021;61(6):900-909. [FREE Full text] [CrossRef] [Medline]
- Guest G, Namey E, McKenna K. How many focus groups are enough? Building an evidence base for nonprobability sample sizes. Field Methods. Jul 24, 2016;29(1):3-22. [CrossRef]
- Hipwell AE, Sturt J, Lindenmeyer A, Stratton I, Gadsby R, O'Hare P, et al. Attitudes, access and anguish: a qualitative interview study of staff and patients' experiences of diabetic retinopathy screening. BMJ Open. Dec 15, 2014;4(12):e005498. [FREE Full text] [CrossRef] [Medline]
- Alexander R. Factors that influence the receipt of eye care. Am J Health Behav. 2008;32(5):547-556. [CrossRef]
- Holtzblatt K, Beyer H. Green T, editor. Contextual Design 2nd Edition: Design for Life. Burlington, MA. Elsevier: Morgan Kaufman; 2017.
- Lundeen EA, Burke-Conte Z, Rein DB, Wittenborn JS, Saaddine J, Lee AY, et al. Prevalence of diabetic retinopathy in the US in 2021. JAMA Ophthalmol. Aug 01, 2023;141(8):747-754. [FREE Full text] [CrossRef] [Medline]
- Jampol LM, Glassman AR, Sun J. Evaluation and care of patients with diabetic retinopathy. N Engl J Med. Apr 23, 2020;382(17):1629-1637. [CrossRef]
- Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. Aug 07, 2009;4:50. [FREE Full text] [CrossRef] [Medline]
- Vindrola-Padros C, Johnson GA. Rapid techniques in qualitative research: a critical review of the literature. Qual Health Res. Aug 2020;30(10):1596-1604. [CrossRef] [Medline]
- Rusch A, Carley I, Badola P, Liebrecht C, McInnis M, Ryan KA, et al. Digital mental health interventions for chronic serious mental illness: findings from a qualitative study on usability and scale-up of the Life Goals app for bipolar disorder. Front Digit Health. 2022;4:1033618. [FREE Full text] [CrossRef] [Medline]
- Miro. URL: https://miro.com/signup/ [accessed 2025-10-16]
- Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, et al. Diabetic retinopathy preferred practice pattern®. Ophthalmology. Jan 2020;127(1):P66-P145. [CrossRef] [Medline]
- Harris Nwanyanwu K, Talwar N, Gardner TW, Wrobel JS, Herman WH, Stein JD. Predicting development of proliferative diabetic retinopathy. Diabetes Care. Jun 2013;36(6):1562-1568. [FREE Full text] [CrossRef] [Medline]
- Krueger RA, Casey MA. Focus Groups: A Practical Guide for Applied Research. Thousand Oaks, CA. Sage Publications Inc; Apr 26, 2000.
- Vissandjée B, Abdool SN, Dupéré S. Focus groups in rural Gujarat, India: a modified approach. Qual Health Res. Jul 2002;12(6):826-843. [CrossRef] [Medline]
- Willgerodt MA. Using focus groups to develop culturally relevant instruments. West J Nurs Res. Nov 2003;25(7):798-814. [CrossRef] [Medline]
- Morgan DL. Successful Focus Groups Advancing the State of the Art. Thousand Oaks, CA. SAGE Publications, Inc; 1993.
- Morgan DL. Why things (sometimes) go wrong in focus groups. Qual Health Res. Nov 01, 1995;5(4):516-523. [CrossRef]
- Morgan DL. Focus Groups as Qualitative Research, 2nd Edition. Thousand Oaks, CA. SAGE Publications; 1997.
- Clark MJ, Cary S, Diemert G, Ceballos R, Sifuentes M, Atteberry I, et al. Involving communities in community assessment. Public Health Nurs. 2003;20(6):456-463. [CrossRef] [Medline]
Abbreviations
| CHIL: Consumer Health Informatics Lab |
| COREQ: Consolidated Criteria for Reporting Qualitative Research |
| DR: diabetic retinopathy |
| RE-AIM: Reach, Effectiveness, Adoption, Implementation, and Maintenance |
| SEEN: Sight-Saving Engagement and Evaluation in New Haven |
Edited by A Schwartz; submitted 02.Sep.2024; peer-reviewed by G Lim, A Jafarizadeh; comments to author 28.Jan.2025; revised version received 28.Mar.2025; accepted 28.Jul.2025; published 12.Nov.2025.
Copyright©Akua Frimpong, Alvaro Granados, Thomas Chang, Julia Fu, Serina S Applebaum, Shannan G Moore, Mahima Kaur, Bolatito Adepoju, Vignesh Hari Krishnan, Amanda Levi, Terika McCall, Kristen Harris Nwanyanwu. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 12.Nov.2025.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.

